Concluding remarks: putting methods to practice

Abstract

This chapter synthesizes the key themes and methodologies discussed throughout the book, focusing on how they can be practically applied to healthcare decision-making. It highlights the role of real-world data (RWD) and innovative statistical approaches in addressing limitations of randomized controlled trials (RCTs), providing evidence for regulatory decision-making, health technology assessment, and personalized medicine. The chapter emphasizes that while RCTs remain fundamental, RWD and RWE are increasingly essential for generating insights in contexts where traditional trials are impractical or unethical. Additionally, the chapter explores the integration of precision medicine in drug development and post-marketing research, outlining challenges such as the co-development of companion diagnostics and patient recruitment strategies. It concludes with a forward-looking perspective on emerging technologies and the need for rigorous methodologies to ensure that these innovations improve patient outcomes and align with broader healthcare goals.

Ähnliche Arbeiten